You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 17, September 22, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Randomized Controlled Trial
 •Gastrointestinal Diseases
 •Alert me on articles by topic

Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer

A 5-Year Prospective, Randomized, Controlled Study

Chen-Chiung Liu, MD; Chia-Long Lee, MD; Chung-Chuan Chan, MD; Tien-Chien Tu, MD; Chien-Chung Liao, MD; Chi-Hwa Wu, MD; Tzen-Kwan Chen, MD

Arch Intern Med. 2003;163:2020-2024.

Background  It is well accepted that in patients with uncomplicated peptic ulcers, Helicobacter pylori eradication therapy does not need to be followed by further antisecretory treatment. However, it is uncertain whether patients with bleeding peptic ulcers should receive maintenance antiulcer therapy after successful H pylori eradication and ulcer healing. The aim of this 5-year, prospective, randomized, controlled study was to investigate the role of long-term maintenance therapy after successful H pylori eradication and healing of bleeding ulcers.

Methods  A total of 82 consecutive patients with H pylori–associated bleeding peptic ulcers were enrolled in the study. After successful H pylori eradication with the 1-week proton pump inhibitor–based triple therapy and an additional 3-week treatment with 20 mg of omeprazole daily for ulcer healing, the patients were assigned to one of four 16-week maintenance treatment groups as follows: group A received 15 mL of an antacid suspension 4 times daily; group B received 300 mg of colloidal bismuth subcitrate 4 times daily; group C received 20 mg of famotidine twice daily; and group D, the control group, received placebo twice daily. Follow-up included an urea breath test labeled with carbon 13, biopsy-based tests, and repeated endoscopic examination.

Results  An analysis of variance revealed no difference in mean age and mean follow-up time among the groups. During a mean follow-up of 56 months, there was no peptic ulcer recurrence among the 3 treatment groups, and all of the patients remained free of H pylori infection during the study period.

Conclusions  In patients with bleeding peptic ulcers, antiulcer maintenance treatment was not necessary to prevent ulcer recurrence after successful H pylori eradication and ulcer healing. In addition, the 1-week proton pump inhibitor–based triple therapy had the efficacy to ensure long-term eradication of H pylori in a region of high prevalence.


From the Division of Gastroenterology, Department of Internal Medicine, Cathay General Hospital (Drs Liu, Lee, Chan, Tu, Liao, Wu, and Chen), and the School of Medicine, Taipei Medical University (Dr Lee), Taipei, Taiwan. The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pathogenesis of Helicobacter pylori Infection
Kusters et al.
Clin. Microbiol. Rev. 2006;19:449-490.
ABSTRACT | FULL TEXT  

Is Maintenance Therapy Needed After H. pylori Eradication and Healing of Bleeding Peptic Ulcer?
JWatch Gastroenterology 2004;2004:8-8.
FULL TEXT  

Minerva
BMJ 2003;327:E268-268.
FULL TEXT  

Minerva
BMJ 2003;327:818-818.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.